<DOC>
	<DOCNO>NCT02708576</DOCNO>
	<brief_summary>The purpose study determine safety tolerability NGM313 , single dose multiple dos , normal healthy overweight obese adult participant .</brief_summary>
	<brief_title>Phase 1 Study NGM313 Healthy Adult Participants</brief_title>
	<detailed_description />
	<criteria>BMI range 2740 kg/m2 , inclusive SAD module , 2740 kg/m2 , inclusive MAD module ; Normal clinical laboratory evaluation Normal ECG finding Significant history clinical manifestation significant metabolic , allergic , dermatological , hepatic , renal , hematological , pulmonary , cardiovascular , gastrointestinal , neurological , psychiatric disorder Uncontrolled hypertension define sit blood pressure systolic &gt; 150 mm/Hg and/or diastolic &gt; 90 mm/Hg</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>